Inhaled nitric oxide to newborns and infants after congenital heart surgery on cardiopulmonary bypass

Scandinavian Cardiovascular Journal

Volumn 34, Issue 2, 2000, Pages 154-158

  Gothberg S ^a   Edberg, K E ^a  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Cardiopulmonary bypass; Children; Congenital heart defect; Inhaled nitric oxide; New born; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE; OXYGEN;

ARTERIAL OXYGEN TENSION; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SYSTEM; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART SURGERY; HUMAN; INFANT; LUNG ARTERY PRESSURE; MALE; NEWBORN; POSTOPERATIVE CARE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY SYSTEM;

ADMINISTRATION, INHALATION; CARDIOPULMONARY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; MALE; NITRIC OXIDE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 0034462042     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430050142161     Document Type: Article

References (33)

1. Pulmonary hypertensive crises following surgery for congenital heart defects in young children
2. Diagnosis and management of postoperative pulmonary hypertensive crisis
3. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary haemodynamics
4. Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary bypass
5. Time course of endothelin-1 and nitrate anion levels after cardiopulmonary bypass in congenital heart defects
6. Nitric oxide activity in patients undergoing cardiopulmonary bypass
7. Studies on relaxation of rabbit aorta by sodium nitrate: The basis for the proposal that the acid activitable inhibitory factor from the bovine retractor penis is inorganic nitrate and the endothelium-derived relaxing oxide
8. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical
9. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
10. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
11. Inhaled "endothelium derived-relaxing factor" (EDRF) in primary pulmonary hypertension (PPH)
12. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
13. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide
14. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
15. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
16. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: A randomised controlled trial
17. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn
18. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease
19. Inhaled nitric oxide in congenital heart disease
20. Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease
21. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients
22. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations
23. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects
24. Very-low-dose inhaled nitric oxide: A selective pulmonary vasodilator after operations for congenital heart disease
25. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass
26. Pulmonary vasodilatory effects of 12 and 60 parts per million inhaled nitric oxide in children with ventricular septal defect
27. Nitric oxide, oxygen and prostacyclin in children with pulmonary hypertension
28. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension
29. Nitric oxide and nitrogen dioxide as inducers of acute pulmonary injury when inhaled at relatively high concentrations for brief periods
30. Conversion of inhaled nitric oxide to nitrate in man
31. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study
32. Inverse relationship between age-dependent erythrocyte activity of methaemoglobin reductase and prilocaine-induced methaemoglobinaemia during infancy
33. Methaemoglobin during nitric oxide therapy with high-frequency ventilation